Abstract

Purpose – Despite the progression of recreational cannabis legalization, the legal system remains the largest…

OPEC+, which is led by Saudi Arabia and Russia, announced this week that it is cutting oil output by 1.2 million barrels per day starting in May. This amounts to removing roughly 1% of oil from the global market. Our experts discuss the far-reaching consequences of this move for U.S. gas prices, American energy security, and U.S.-Saudi relations. 

On March 20, 2003, U.S. air and ground forces invaded Iraq under the direction of former President George W. Bush. Ambassador Satterfield discusses lessons learned from the U.S. diplomatic and military strategy following the tragic events of 9/11 that led to the invasion of Iraq in 2003.

In the United States, drug overdose deaths are on the rise. In 2022, CDC researchers reported that 110,236 people died from an overdose in a single 12-month period, setting a new record. Synthetic opioid overdose deaths, primarily due to fentanyl, increased nearly 7.5-fold from 2015 to 2021. In Texas, the number of fentanyl-related deaths rose dramatically — from 883 deaths in 2020 to 1,672 deaths in 2021. While Republican lawmakers in Texas have previously opposed harm reduction policies, many have signaled a desire to take policy action to combat the crisis in the 2023 legislative session.

Abstract

Scholars began reporting about this marketplace in the mid-2000s; however, there is no sign of it dissipating…

Vaccination policies are a cornerstone of public health, but anti-vaccine activists have been adamantly pushing for legislation that would weaken and dismantle the public health infrastructure, the authors write. In this issue brief, they examine vaccine policy challenges leading up to and during the COVID-19 pandemic, as well as the future of vaccine legislation in Texas and the United States.

The authors identify key themes that emerged from anti-vaccine testimonies during the 2021 Texas legislative session and consider the implications of these discussions as the next legislative session draws near.

There have been promising developments in recent years in the fight to reduce overdose deaths. But barriers to drug checking and other overdose prevention tools remain throughout the country, writes fellow Katharine Neill Harris.

Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).